Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: Results from two early-phase randomized trials.
Diabetes Obes Metab
; 23(3): 700-710, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33289350
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
Type of study:
Clinical_trials
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2021
Type:
Article